Trial will test stem cells as cerebral palsy treatment

02/12/2010 | Disability Scoop

Researchers at the Medical College of Georgia are preparing to start the first FDA-approved clinical study of the effectiveness of using umbilical cord-blood stem cells as treatment for cerebral palsy. The trial will involve 40 patients ages 2 to 12. Doctors will examine the patients for improvements three months, six months and nine months into the trial.

View Full Article in:

Disability Scoop

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN